MOLECULAR PHARMACEUTICS Q1

期刊简介

Molecular Pharmaceutics publishes original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:

Modelling and simulation to aid mechanistic insights into drug delivery
Molecular understanding of formulations
Formulation performance under physiological conditions
Materials science as it relates to drug, excipients and drug delivery system efficacy.
Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.

《MOLECULAR PHARMACEUTICS》期刊已被查看： 次
期刊简写：Mol. Pharmaceutics

此期刊被最新的JCR期刊SCIE收录

期刊信息

分区信息

• 上一篇： MOLECULAR CANCER THERAPEUTICS
• 下一篇：Lymphatic Research and Biology